Atlas Trials

Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients

Clinical trial NCT04557007 · TERMINATED

Trial details

NCT number
NCT04557007
Sponsor
Oslo University Hospital
Status
TERMINATED
Study type
OBSERVATIONAL
NSCLC
Start date
2020-09-01
Primary completion
2022-10-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.